Changing Treatment Paradigms to Optimize Outcomes for Patients With Type 1 Gaucher Disease: A Case-Based Approach

Gregory Pastores, MD
Associate Professor of Neurology and Pediatrics
New York University School of Medicine
Director of the Neurogenetics Laboratory
Department of Neurology
New York University
New York, New York


Atul Mehta, MD, FRCP, FRCPath
Royal Free Hospital
Department of Haematology
University College London School
   of Medicine
London, England

Pilar Giraldo, MD, PhD
Associate Professor of Hematology
Miguel Servet University
Head of Clinical Hematology
Hematology Department
Miguel Servet University Hospital
Zaragoza, Spain

For more information, please visit the National Gaucher Foundation at